V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007686 | 220003045 | 1.82 | 72.8 | null | 2013-11-01 | 2013-11-01 | CARBOPLATIN + PACLITAXEL | N | N | 220032927 | CARBOPLATIN + PACLITAXEL |
| 220007687 | 220003046 | 1.58 | 64.4 | Curative (C) | 2014-03-22 | 2014-03-23 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032928 | CARBOPLATIN + PACLITAXEL |
| 220007688 | 220003046 | null | 94.7 | null | 2014-10-18 | 2014-10-23 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032928 | CISPLATIN + GEMCITABINE |
| 220007689 | 220003046 | 1.82 | 84.5 | Disease modification (D) | 2017-03-05 | 2017-03-05 | Idarubicin+Tretinoin Spanish Crse4 | 2 | N | 220032928 | IDARUBICIN + TRETINOIN |
| 220007690 | 220003046 | 1.78 | 156.4 | Curative (C) | 2017-10-20 | 2017-10-20 | AML 18 TRIAL | Y | N | 220032928 | AML18 TRIAL |
| 220007691 | 220020436 | 1.87 | 67.3 | Curative (C) | 2015-04-12 | 2015-04-12 | IDARUBICIN + TRETINOIN | N | N | 220032937 | IDARUBICIN + TRETINOIN |
| 220007692 | 220021290 | 1.44 | null | Curative (C) | null | 2014-11-28 | AML18 PILOT TRIAL | N | N | 220032942 | PILOT TRIAL |
| 220007693 | 220003047 | 1.71 | 75.6 | Disease modification (D) | 2013-02-01 | 2013-02-02 | IDARUBICIN + TRETINOIN | 02 | N | 220032943 | IDARUBICIN + TRETINOIN |
| 220007694 | 220011705 | 1.73 | 61 | Palliative (P) | 2016-08-19 | 2016-08-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032948 | CARBOPLATIN + PACLITAXEL |
| 220007695 | 220011705 | 1.69 | 75.9 | Curative (C) | 2013-05-29 | 2013-05-29 | AML18 PILOT TRIAL | Y | Y | 220032948 | PILOT TRIAL |
| 220007696 | 220011705 | 1.82 | 92 | Neo-adjuvant (N) | 2013-08-14 | 2013-08-17 | AML 18 TRIAL | 01 | N | 220032948 | AML18 TRIAL |
| 220007697 | 220011705 | 1.77 | 82.3 | Curative (C) | null | 2015-03-26 | Carboplatin + Paclitaxel (3 weekly) | null | null | 220032948 | CARBOPLATIN + PACLITAXEL |
| 220007698 | 220003048 | null | 67.3 | Disease modification (D) | 2016-12-13 | 2016-12-16 | AML18 PILOT TRIAL | N | N | 220032956 | PILOT TRIAL |
| 220007699 | 220003049 | 1.68 | 82.1 | null | 2016-09-19 | 2016-09-25 | AML16 DA 3+8 | 02 | N | 220032957 | AML16 TRIAL |
| 220007700 | 220003050 | null | 80 | Palliative (P) | 2017-08-08 | 2017-08-08 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220032960 | CISPLATIN + GEMCITABINE |
| 220007701 | 220003051 | 1.73 | 101 | Disease modification (D) | 2014-11-06 | 2014-11-25 | AML16 DA 3+10 | N | null | 220032961 | AML16 TRIAL |
| 220007702 | 220003052 | 1.61 | null | Disease modification (D) | null | 2016-01-01 | AML16 DA 3+10 | N | null | 220032964 | AML16 TRIAL |
| 220007703 | 220003053 | null | null | Curative (C) | 2015-06-16 | 2015-06-16 | AML 18 TRIAL | Y | N | 220032967 | AML18 TRIAL |
| 220007704 | 220003053 | 1.64 | 48.1 | Palliative (P) | 2014-08-24 | 2014-10-04 | Cisplatin+Gemcitabine (gallbladder) | N | N | 220032967 | CISPLATIN + GEMCITABINE |
| 220007705 | 220003053 | null | 47 | Neo-adjuvant (N) | 2014-05-03 | 2014-05-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220032967 | CARBOPLATIN + PACLITAXEL |
| 220007706 | 220003053 | 1.65 | 59.9 | Curative (C) | 2015-10-19 | 2015-11-30 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220032967 | IDARUBICIN + TRETINOIN |
| 220007707 | 220003053 | 1.86 | 77.2 | Palliative (P) | 2013-04-21 | 2013-05-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032967 | CARBOPLATIN + PACLITAXEL |
| 220007708 | 220003054 | 1.7 | null | Curative (C) | null | 2017-04-11 | AML16 DA 3+10 | 02 | null | 220032980 | AML16 TRIAL |
| 220007709 | 220003055 | 1.73 | 54 | Disease modification (D) | 2013-03-04 | 2013-09-23 | AML18 PILOT TRIAL | 1 | null | 220032982 | PILOT TRIAL |
| 220007710 | 220003055 | null | 154.9 | Curative (C) | 2015-07-12 | 2015-07-13 | AML 18 TRIAL | Y | null | 220032982 | AML18 TRIAL |
| 220007711 | 220003056 | null | 74 | Curative (C) | 2016-04-14 | 2016-04-14 | AML16 DA 3+10 | N | N | 220032988 | AML16 TRIAL |
| 220007712 | 220003057 | 1.75 | null | null | 2016-07-13 | 2016-07-18 | GEMCARBO | N | N | 220032990 | GEMCARBO |
| 220007713 | 220003057 | 1.78 | 83.4 | Disease modification (D) | 2015-02-04 | 2015-02-05 | AML16 DA 3+10 | N | N | 220032990 | AML16 TRIAL |
| 220007714 | 220003058 | 1.75 | 80 | Disease modification (D) | null | 2016-09-06 | AML16 DA 3+10 | Y | N | 220032993 | AML16 TRIAL |
| 220007715 | 220003059 | 1.63 | 126 | Curative (C) | 2013-04-01 | 2013-05-10 | Carboplatin 21day + Paclitaxel 7day | N | N | 220032994 | CARBOPLATIN + PACLITAXEL |
| 220007716 | 220003059 | 1.8 | null | Curative (C) | 2017-09-12 | 2017-09-13 | AML 18 TRIAL | 01 | N | 220032994 | AML18 TRIAL |
| 220007717 | 220003059 | 1.84 | null | Curative (C) | 2014-04-05 | 2014-04-05 | AML 18 Pilot Trial | 1 | N | 220032994 | PILOT TRIAL |
| 220007718 | 220003059 | 1.74 | 119 | Disease modification (D) | null | 2017-07-02 | AML 18 TRIAL | N | N | 220032994 | AML18 TRIAL |
| 220007719 | 220003060 | 1.8 | 72 | Palliative (P) | 2016-03-08 | 2016-02-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032998 | CARBOPLATIN + PACLITAXEL |
| 220007720 | 220003060 | null | 84 | null | 2017-08-01 | 2017-08-20 | Dasatinib | 02 | null | 220032998 | DASATINIB |
| 220007721 | 220003060 | 1.65 | null | Curative (C) | 2016-04-11 | 2016-04-11 | AML 18 TRIAL | Y | N | 220032998 | AML18 TRIAL |
| 220007722 | 220018927 | null | null | Palliative (P) | 2017-08-16 | 2017-08-16 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220033004 | CISPLATIN + GEMCITABINE |
| 220007723 | 220003061 | 1.75 | 0 | Palliative (P) | 2013-05-02 | 2013-05-26 | CARBOPLATIN + PACLITAXEL | N | N | 220033009 | CARBOPLATIN + PACLITAXEL |
| 220007724 | 220003062 | 1.6 | 61.7 | Curative (C) | 2013-12-01 | 2013-12-02 | IDARUBICIN + TRETINOIN | Y | N | 220033010 | IDARUBICIN + TRETINOIN |
| 220007725 | 220003062 | 1.64 | 125 | Neo-adjuvant (N) | 2017-02-01 | 2017-02-01 | AML 18 TRIAL | N | N | 220033010 | AML18 TRIAL |
| 220007726 | 220003063 | null | 68 | Palliative (P) | 2016-06-27 | 2016-06-27 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220033012 | CARBOPLATIN + PACLITAXEL |
| 220007727 | 220003063 | null | 73.2 | Disease modification (D) | 2018-01-25 | 2018-01-25 | Dasatinib | 2 | N | 220033012 | DASATINIB |
| 220007728 | 220003063 | 1.47 | 75 | null | 2017-09-10 | 2017-09-10 | CISPLATIN + GEMCITABINE | null | N | 220033012 | CISPLATIN + GEMCITABINE |
| 220007729 | 220003063 | 1.7 | 107.6 | Disease modification (D) | null | 2013-03-09 | AML16 DA 3+10 | N | N | 220033012 | AML16 TRIAL |
| 220007730 | 220003063 | 1.59 | 70.8 | Curative (C) | null | 2015-11-11 | AML18 PILOT TRIAL | Y | N | 220033012 | PILOT TRIAL |
| 220007731 | 220021291 | null | 68.2 | Curative (C) | 2015-11-23 | 2015-11-23 | AML16 DA 3+10 | N | N | 220033027 | AML16 TRIAL |
| 220007732 | 220003064 | 1.56 | 70 | Curative (C) | 2014-12-03 | 2014-12-03 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220033029 | CARBOPLATIN + PACLITAXEL |
| 220007733 | 220003065 | 1.71 | 76.9 | Curative (C) | 2015-10-17 | 2015-10-19 | AML18 PILOT TRIAL | Y | N | 220033032 | PILOT TRIAL |
| 220007734 | 220003065 | 1.79 | 86 | Disease modification (D) | 2017-08-11 | 2017-08-11 | Dasatinib | 2 | N | 220033032 | DASATINIB |
| 220007735 | 220003066 | null | 107.6 | Curative (C) | 2016-08-04 | 2016-08-22 | AML 18 TRIAL | Y | N | 220033036 | AML18 TRIAL |